Cardiac troponin and outcome in acute heart failure.

By W. Peacock, T. De Marco, G. Fonarow, D. Diercks, Janet Wynne, F. Apple, A. Wu. New England Journal of Medicine, 2008

726 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/246a5f84f09093eff9048747124fc9f75f55c1c5

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

Citations in the corpus

Acute heart failure syndromes (2009, background): “In both roups, the presence and extent of CAD may determine the nitial, in-hospital, and post-discharge management (36).”
2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2013, background): “treatment and initiation of standard medical therapy for HF (149).”
The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. (2014, background): “, blood urea nitrogen and serum creatinine) (42,69), serum sodium (41), hemoglobin (40), NP concentration (70,71), troponin (71,72), QRS duration (43,71), and evidence-based medication utilization (73,74).”
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. (2017, background): “Similarly, abnormal levels of circulating cardiac troponin arecommonly found inpatientswithacute decompensatedHF, oftenwithout obviousmyocardial ischemia or underlying coronary artery disease (CAD), and this is associated with worse clinical outcomes and higher risk of death (95,99,102,103).”
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013, background): “Downloa associated with worse clinical outcomes and mortality (253,257,263); decrease in troponin levels over time with treatment is associated with a better prognosis than persistent elevation in patients with chronic (239) or acute HF (277).”